Evidence brief · printable

Attention Deficit-Hyperactivity Disorder evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Attention Deficit-Hyperactivity Disorder

Print or save as PDF Fits on one A4 or Letter page.

Attention Deficit-Hyperactivity Disorder: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,012 matching trials) · https://research.opensourcemed.info/briefs/attention-deficit-hyperactivity-disorder.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Atomoxetine 5 trials
  • Methylphenidate 5 trials
  • Centanafadine SR 2 trials
  • Concerta 2 trials
  • Lisdexamfetamine 2 trials
  • OROS methylphenidate HCl 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Omega-3 fatty acids and fish oil 12 trials · 10 completed · 4 with results
  • Transcranial brain stimulation (tDCS, TMS) 29 trials · 14 completed · 3 with results
  • Virtual reality 23 trials · 8 completed · 3 with results
  • Cognitive behavioural and related therapies 34 trials · 22 completed · 2 with results
  • Cognitive training and remediation 24 trials · 19 completed · 2 with results
  • Education, coaching and self-management 25 trials · 11 completed · 2 with results

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients NCT06931080
  • A Long-term Trial of EB-1020 in Adult Patients With ADHD NCT06926829
  • Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2) NCT07717879
  • Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive… NCT04296604
  • Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation NCT05802680
  • SKIP for PA Study: Team and Leadership Level Implementation Support for… NCT04946253

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Mind-body and psychological approaches: mood, anxiety and wellbeing 22 trials, no results posted yet
  • Cognitive training and education: cognition 21 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (475 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.